[Current therapeutic aspects of Trichomonas vaginalis infections in gynecology].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to F Sesti.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In the present work, on the basis of the most current knowledges, the Authors analyse and discuss the pharmacological and clinical aspects of the different types of chemotherapeutic treatment (single agent chemotherapy, multidrug chemotherapy, combined cytotoxic and hormonal chemotherapy) tested on patients with advanced or recurrent endometrial carcinoma.
In the present work, on the basis of the most recent knowledges, tha Authors analyse and discuss the pharmacological and clinical aspects of the different types of adjuvant and first-line chemotherapeutical treatment of the ovarian cancer (single agent chemotherapy and multidrug chemotherapy).
In the present work, on the basis of the most recent knowledges, the Authors analyse and discuss the current status of the chemotherapeutical treatment of epidermoid carcinomas of the vulva and vagina, both in case of in situ forms (topical chemotherapeutic administration) and in case of invasive tumors (systemic chemotherapeutic administration).
In the present work, on the basis of the most recent knowledges, the Authors analyse and discuss the pharmacological and clinical aspects of the different types of second-line chemotherapeutical treatment for refractory ovarian cancer (standard single agent chemotherapy in high-dose schedules, new investigational anticancer agents, multidrugs chemotherapy, intraperitoneal chemotherapy).
In the present work, on the basis of the most current knowledges, the Authors analyse and discuss the pharmacological and clinical aspects of the chemotherapy of salvage for the advanced or recurrent tumoral forms, and of the "neoadjuvant" chemotherapy, employed before of surgery or radiotherapy during the primary treatment of cervical cancer.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.